Tech Company Financing Transactions

Potenza Therapeutics Funding Round

Potenza Therapeutics, based in Cambridge, raised $5 million from private investors.

Transaction Overview

Announced On
12/30/2017
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
700 Main St. North
Cambridge, MA 02139
USA
Email Address
Overview
Potenza Therapeutics is focusing on the discovery and development of novel immune-oncology therapeutics: Molecules that stimulate the power of the immune system to fight cancer.
Profile
Potenza Therapeutics LinkedIn Company Profile
Social Media
Potenza Therapeutics Company Twitter Account
Company News
Potenza Therapeutics News
Facebook
Potenza Therapeutics on Facebook
YouTube
Potenza Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Lisa Velardo
  Lisa Velardo LinkedIn Profile  Lisa Velardo Twitter Account  Lisa Velardo News  Lisa Velardo on Facebook
Co-Founder
Peter Parker
  Peter Parker LinkedIn Profile  Peter Parker Twitter Account  Peter Parker News  Peter Parker on Facebook
Controller
Abby Johnson
  Abby Johnson LinkedIn Profile  Abby Johnson Twitter Account  Abby Johnson News  Abby Johnson on Facebook
President
Johannes Fruehauf
  Johannes Fruehauf LinkedIn Profile  Johannes Fruehauf Twitter Account  Johannes Fruehauf News  Johannes Fruehauf on Facebook
VP - Operations
Krista Licata
  Krista Licata LinkedIn Profile  Krista Licata Twitter Account  Krista Licata News  Krista Licata on Facebook
VP - Operations
Maggie O'Toole
  Maggie O'Toole LinkedIn Profile  Maggie O'Toole Twitter Account  Maggie O'Toole News  Maggie O'Toole on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/29/2017: Clinical Ink venture capital transaction
Next: 12/30/2017: Elira Therapeutics venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary